Eduardo Schenberg
As a Member, you’re not just making a donation — you’re joining a community that is at the forefront of advancing research, changing policy, and evolving education around psychedelics. Join us in shaping a future where these life-changing tools are available to those who need them most.
Session explores health equity challenges and opportunities in mainstream psychedelic therapy, focusing on experiences of 3 women of color. Topics include overcoming inequity, cultural trauma, power dynamics, and ancestral healing.
Claudia Cuentas, Sara Reed, Deran Young
Psychedelic experiences' impact on long-term outcomes in mood and wellbeing varies based on the nature of the experience, set and setting, and individual variables. Data from a psilocybin clinical trial
Tomáš Páleníček
Panel explores reciprocity in global plant medicine spaces, focusing on disparities in psychedelic renaissance participation between Global North and South communities, emphasizing Indigenous perspectives and advocating for decolonization. Discussions include
Marlena Robbins, Joseph Mays
TREAT California initiative aims to transform mental healthcare in California with $5 Billion funding for psychedelic medicine research and access, inspired by successful stem cell agency model.
Jeannie Moller Fontana
Peyote's historical significance as a sacrament faces sustainability challenges due to increased psychedelic use and ecological threats. Discussion focuses on legal and environmental protection for future generations.
Steven S Benally, Lucy Benally, Forrest Tahdooahnippah
Mexican lawmakers and advocates explore opening access to psychedelics while protecting Indigenous heritage. Efforts intersect with and differ from US approaches.
Natalia Rebollo Corral, Mexican Senator Alejandra Lagu…
Dr. Harris shares insights from interviews with women elders guiding long-term underground psychedelic journeys, focusing on themes like self-healing, apprenticeship, and relationships with medicines. These priestesses offer an alternative perspective
Rachel Harris
Research on psilocybin mushroom use in Mesoamerica explores archeological evidence from Maya, Mixtecs, and Aztecs through various sources, aiming to encourage interpretations based on scientific evidence and a humanistic approach.
Osiris Sinuhé González Romero
David Bronner, Cosmic Engagement Officer of Dr. Bronner’s, discusses integrating psychedelic medicines into U.S. society, comparing regulated access to self-regulating communities and churches, examining equitable access and impacts on Indigenous
David Bronner
© 1986 – 2025 Multidisciplinary Association for Psychedelic Studies. All Rights Reserved.
3141 Stevens Creek Blvd #40563, San Jose, CA 95117.
Mailing: MAPS P.O. Box 103004 Pasadena, CA 91189-3004.